等待開盤 11-07 09:30:00 美东时间
-0.010
-0.05%
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
11-04 10:31
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
Alkami Technology Inc (ALKT) has disclosed a new risk, in the Accounting & ...
11-01 14:00
Alkami Technology (NASDAQ:ALKT) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.12 by 7.44 percent. This is a 244.44 percent increase over losses of $(0.09) per share from
10-31 05:28
Alkami Technology shares are trading lower after the company reported worse-tha...
10-31 05:05
Alkami Technology, Inc. (Nasdaq: ALKT) ("Alkami"), a digital sales and service platform provider for financial institutions in the U.S., announced today the appointment of Cassandra Hudson as its Chief Financial Officer
10-31 04:23
Alkami Technology (NASDAQ:ALKT) lowers FY2025 sales outlook from $443.000 million-$447.000 million to $442.500 million-$444.000 million vs $444.953 million estimate.
10-31 04:13
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
Highlighting platform innovation, problem-solving, and community-driven teamwork PLANO, Texas, Oct. 9, 2025 /PRNewswire/ -- Alkami Technology, Inc. (Nasdaq: ALKT) ("Alkami"), a digital sales...
10-09 22:00
IDC Financial Insights ranks top enterprises worldwide serving the financial services industry PLANO, Texas, Sept. 30, 2025 /PRNewswire/ -- Alkami Technology, Inc. (Nasdaq: ALKT) ("Alkami"),...
09-30 22:00